Cite
HARVARD Citation
Rouzier, R. et al. (2017). Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial. European journal of cancer. pp. 133-142. [Online].